Pharmaceutical, biotechnology, and medical device organizations are increasingly managing complex global safety operations that span multiple vigilance domains — drug, device, cosmetic, veterinary, and nutritional. Traditional, siloed safety systems often lead to data fragmentation, manual effort, compliance risks, and higher operational costs.
Cloudbyz Multi-Vigilance, built natively on the Salesforce platform, redefines how organizations manage end-to-end safety and post-market surveillance. By unifying all vigilance processes into a single, intelligent, and configurable environment, Cloudbyz empowers teams to achieve higher efficiency, reduce total cost of ownership, and accelerate innovation across the product lifecycle.
Cloudbyz Multi-Vigilance brings together pharmacovigilance, device vigilance, cosmetovigilance, and veterinary vigilance into one seamless platform. Instead of managing multiple point solutions, safety teams can harmonize data collection, signal management, and regulatory reporting under a unified framework.
This unified architecture enables consistent workflows, centralized case repositories, and standardized compliance processes aligned with ICH E2B(R3), ISO IDMP, MDR, and FDA post-market surveillance requirements. Organizations gain real-time visibility across all vigilance domains — breaking down silos and enabling proactive safety intelligence.
Built natively on Salesforce, Cloudbyz Multi-Vigilance inherits the scalability, reliability, and configurability of the world’s leading cloud platform. The solution leverages Salesforce Flow, Einstein AI, and Agentforce AI to automate repetitive safety operations — from triage and duplicate detection to case routing and narrative generation.
This automation drastically reduces manual workload, shortens case processing time, and ensures high data accuracy. Moreover, the platform’s role-based dashboards, real-time analytics, and configurable workflows allow safety, regulatory, and quality teams to collaborate seamlessly while maintaining full audit trails and data integrity.
Organizations traditionally maintain separate systems for each vigilance type — resulting in duplicate infrastructure, disconnected data, and higher maintenance costs. Cloudbyz eliminates this redundancy by providing a single platform that scales horizontally across multiple vigilance domains.
By leveraging the Salesforce multi-tenant architecture, companies can reduce IT overhead, eliminate integration costs, and consolidate licensing and validation efforts. The result is significant total cost of ownership (TCO) reduction, faster deployment cycles, and simplified compliance validation aligned with GAMP 5 and 21 CFR Part 11 guidelines.
Innovation in vigilance is no longer limited to automation — it’s about intelligence. Cloudbyz integrates AI-driven analytics, NLP, and generative AI Agents to transform case data into actionable insights.
AI Agents can perform automated case summarization, signal detection, literature monitoring, and regulatory intelligence scanning to stay ahead of evolving compliance requirements. These AI capabilities, coupled with Salesforce’s Agentforce and Einstein Copilot, enable predictive safety surveillance and proactive risk management, paving the way for next-generation pharmacovigilance.
Cloudbyz Multi-Vigilance ensures alignment with regional and international regulatory bodies such as FDA, EMA, MHRA, PMDA, Health Canada, and ANSM. The platform supports E2B R3 submissions, MedDRA coding, global periodic reporting, and signal management workflows, ensuring traceability from intake to submission.
Automated compliance checks and validation ensure that case data, narratives, and reports meet regulatory quality standards. With configurable dashboards and submission tracking, safety leaders can manage inspections and audits with confidence, minimizing risk while maximizing transparency.
Cloudbyz enables organizations to transform safety operations from a reactive compliance function into a strategic innovation engine. The platform’s modular architecture supports seamless integration with Cloudbyz CTMS, eTMF, EDC, and Clinical Data Management solutions — delivering an end-to-end connected eClinical ecosystem.
This real-time interoperability enables closed-loop safety intelligence — where insights from clinical, post-market, and regulatory data flow continuously, helping life sciences companies improve patient outcomes, enhance compliance readiness, and accelerate time-to-market.
Organizations adopting Cloudbyz Multi-Vigilance have realized measurable improvements, including:
40–60% reduction in manual case processing effort through automation
30–40% lower total cost of ownership via platform consolidation
Improved compliance readiness with audit-ready documentation and analytics
Accelerated innovation cycles through AI-driven vigilance insights
These outcomes reflect not just efficiency gains but also a fundamental shift toward smarter, agile, and proactive safety management.
Cloudbyz Multi-Vigilance, powered by the Salesforce platform, represents the next frontier in unified, intelligent safety management. By merging scalability, automation, and AI-driven intelligence within a single cloud ecosystem, Cloudbyz enables life sciences organizations to deliver safer products, faster decisions, and measurable business impact — while embracing continuous innovation.
In an era where vigilance is both a regulatory mandate and a strategic differentiator, Cloudbyz stands at the forefront — helping organizations turn compliance into competitive advantage.